Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages

British Journal of Pharmacology

Volumn 145, Issue 6, 2005, Pages 800-810

  Sawle, Philip ^a   Foresti, Roberta ^a   Mann, Brian E ^b   Johnson, Tony R ^b   Green, Colin J ^a   Motterlini, Roberto ^a  

^a NORTHWICK PARK INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Carbon monoxide; Carbon monoxide releasing molecules (CO RMs); Heme oxygenase; Inflammation; Nitric oxide

Indexed keywords

ACETYLCYSTEINE; ANTIINFLAMMATORY AGENT; BILIRUBIN; BILIVERDIN; CARBON MONOXIDE; CARBON MONOXIDE RELEASING MOLECULE; CELL ADHESION MOLECULE; CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; FERROUS ION; GLUTATHIONE; HEME OXYGENASE 1; HEMIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRITE; PROTOPORPHYRIN TIN; THIOL DERIVATIVE; TRICARBONYLCHLORO(GLYCINATO)RUTHENIUM; TRICARBONYLDICHLORORUTHENIUM; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; ENZYME ACTIVITY; IN VITRO STUDY; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; CARBON MONOXIDE; CELL LINE; CELL SURVIVAL; GLUTATHIONE; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MEMBRANE PROTEINS; MICE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; ORGANOMETALLIC COMPOUNDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 23044459608     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706241     Document Type: Article

References (35)

1. ALBAKRI, Q.A. & STUEHR, D.J. (1996). Intracellular assembly of inducible NO synthase is limited by nitric oxide-mediated changes in heme insertion and availability. J. Biol. Chem., 271, 5414-5421.
2. CLARK, J.E., FORESTI, R., GREEN, C.J. & MOTTERLINI, R. (2000). Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress. Biochem. J., 348, 615-619.
3. CLARK, J.E., NAUGHTON, P., SHUREY, S., GREEN, C.J., JOHNSON, T.R., MANN, B.E., FORESTI, R. & MOTTERLINI, R. (2003). Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ. Res., 93, e2-e8.
4. DULAK, J., JOZKOWICZ, A., FORESTI, R., KASZA, A., FRICK, M., HUK, I., GREEN, C.J., PACHINGER, O., WEIDINGER, F. & MOTTERLINI, R. (2002). Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells. Antioxid. Redox. Signal., 4, 229-240.
5. FORESTI, R., CLARK, J.E., GREEN, C.J. & MOTTERLINI, R. (1997). Thiol compounds interact with nitric oxide in regulating heme oxygenase-1 induction in endothelial cells. Involvement of superoxide and peroxynitrite anions. J. Biol. Chem., 272, 18411-18417.
6. FORESTI, R., HAMMAD, J., CLARK, J.E., JOHNSON, R.A., MANN, B.E., FRIEBE, A., GREEN, C.J. & MOTTERLINI, R. (2004). Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule. Br. J. Pharmacol., 142, 453-460.
7. FORESTI, R., HOQUE, M., BAINS, S., GREEN, C.J. & MOTTERLINI, R. (2003). Haem and nitric oxide: synergism in the modulation of the endothelial haem oxygenase-1 pathway. Biochem. J., 372, 381-390.
8. FORESTI, R. & MOTTERLINI, R. (1999). The heme oxygenase pathway and its interaction with nitric oxide in the control of cellular homeostasis. Free Rad. Res., 31, 459-475.
9. GUO, Y., STEIN, A.B., WU, W.J., TAN, W., ZHU, X., LI, Q.H., DAWN, B., MOTTERLINI, R. & BOLLI, R. (2004). Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. Am. J. Physiol Heart Circ. Physiol, 286, H1649-H1653.
10. HAYASHI, S., TAKAMIYA, R., YAMAGUCHI, T., MATSUMOTO, K., TOJO, S.J., TAMATANI, T., KITAJIMA, M., MAKINO, N., ISHIMURA, Y. & SUEMATSU, M. (1999). Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress. Role of bilirubin generated by the enzyme. Circ. Res., 85, 663-671.
11. JOHNSON, T.R., MANN, B.E., CLARK, J.E., FORESTI, R., GREEN, C.J. & MOTTERLINI, R. (2003). Metal carbonyls: a new class of pharmaceuticals? Angew. Chem. Int. Ed. Engl., 42, 3722-3729.
12. LEE, T.S. & CHAU, L.Y. (2002). Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat. Med., 8, 240-246.
13. LIN, H.Y., JUAN, S.H., SHEN, S.C., HSU, F.L. & CHEN, Y.C. (2003). Inhibition of lipopolysaccharide-induced nitric oxide production by flavonoids in RAW264.7 macrophages involves heme oxygenase-1. Biochem. Pharmacol., 66, 1821-1832.
14. MACMICKING, J.D., NATHAN, C., HOM, G., CHARTRAIN, N., FLETCHER, D.S., TRUMBAUER, M., STEVENS, K., XIE, Q.W., SOKOL, K., HUTCHINSON, N., CHEN, H. & MUDGETT, J.S. (1995). Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell, 81, 641-650.
15. MCCARTER, S.D., SCOTT, J.R., LEE, P.J., ZHANG, X., CHOI, A.M., MCLEAN, C.A., BADHWAR, A., DUNGEY, A.A., BIHARI, A., HARRIS, K.A. & POTTER, R.F. (2003). Cotransfection of heme oxygenase-1 prevents the acute inflammation elicited by a second adenovirus. Gene Therapy, 10, 1629-1635.
16. MOTTERLINI, R., CLARK, J.E., FORESTI, R., SARATHCHANDRA, P., MANN, B.E. & GREEN, C.J. (2002a). Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ. Res., 90, E17-E24.
17. MOTTERLINI, R., FORESTI, R., BASSI, R., CALABRESE, V., CLARK, J.E. & GREEN, C.J. (2000). Endothelial heme oxygenase-1 induction by hypoxia: modulation by inducible nitric oxide synthase (iNOS) and S-nitrosothiols. J. Biol. Chem., 275, 13613-13620.
18. MOTTERLINI, R., FORESTI, R., INTAGLIETTA, M. & WINSLOW, R.M. (1996). NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. Am. J. Physiol. Heart Circ. Physiol., 270, H107-H114.
19. MOTTERLINI, R., GREEN, C.J. & FORESTI, R. (2002b). Regulation of heme oxygenase-1 by redox signals involving nitric oxide. Antiox. Redox Signal., 4, 615-624.
20. MOTTERLINI, R., MANN, B.E., JOHNSON, T.R., CLARK, J.E., FORESTI, R. & GREEN, C.J. (2003). Bioactivity and pharmacological actions of carbon monoxide-releasing molecules. Curr. Pharm. Des., 9, 2525-2539.
21. MOTTERLINI, R., SAWLE, P., BAINS, S., HAMMAD, J., ALBERTO, R., FORESTI, R. & GREEN, C.J. (2005). CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule. FASEB J., 19, 284-286.
22. NAKAO, A., MOORE, B.A., MURASE, N., LIU, F., ZUCKERBRAUN, B.S., BACH, F.H., CHOI, A.M., NALESNIK, M.A., OTTERBEIN, L.E. & BAUER, A.J. (2003). Immunomodulatory effects of inhaled carbon monoxide on rat syngeneic small bowel graft motility. Gut, 52, 1278-1285.
23. OTTERBEIN, L.E., BACH, F.H., ALAM, J., SOARES, M., TAO LU, H., WYSK, M., DAVIS, R.J., FLAVELL, R.A. & CHOI, A.M. (2000). Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med., 6, 422-428.
24. OTTERBEIN, L.E., SOARES, M.P., YAMASHITA, K. & BACH, F.H. (2003). Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol., 24, 449-455.
25. POSS, K.D. & TONEGAWA, S. (1997). Reduced stress defense in heme oxygenase 1-deficient cells. Proc. Natl. Acad. Sci. U.S.A., 94, 10925-10930.
26. SRISOOK, K. & CHA, Y.N. (2004). Biphasic induction of heme oxygenase-1 expression in macrophages stimulated with lipopolysaccharide. Biochem. Pharmacol., 68, 1709-1720.
27. STAMLER, J.S., LAMAS, S. & FANG, F.C. (2001). Nitrosylation: the prototypic redox-based signaling mechanism. Cell, 106, 675-683.
28. TAILLE, C., FORESTI, R., LANONE, S., ZEDDA, C., GREEN, C.J., AUBIER, M., MOTTERLINI, R. & BOCZKOWSKI, J. (2001). Protective role of heme oxygenases against endotoxin-induced diaphragmatic dysfunction in rats. Am. J. Respir. Crit. Care Med., 163, 753-761.
29. TURCANU, V., DHOUIB, M. & POINDRON, P. (1998). Nitric oxide synthase inhibition by haem oxygenase decreases macrophage nitric-oxide-dependent cytotoxicity: a negative feedback mechanism for the regulation of nitric oxide production. Res. Immunol., 149, 741-744.
30. WAGENER, F.A., VOLK, H.D., WILLIS, D., ABRAHAM, N.G., SOARES, M.P., ADEMA, G.J. & FIGDOR, C.G. (2003). Different faces of the heme-heme oxygenase system in inflammation. Pharmacol. Rev., 55, 551-571.
31. WANG, W.W., SMITH, D.L. & ZUCKER, S.D. (2004). Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats. Hepatology, 40, 424.
32. WHITE, K.A. & MARLETTA, M.A. (1992). Nitric oxide synthase is a cytochrome P-450 type protein. Biochemistry, 31, 6627-6631.
33. WIESEL, P., PATEL, A.P., DIFONZO, N., MARRIA, P.B., SIM, C.U., PELLACANI, A., MAEMURA, K., LEBLANC, B.W., MARINO, K., DOERSCHUK, C.M., YET, S.F., LEE, M.E. & PERRELLA, M.A. (2000). Endotoxin-induced mortality is related to increased oxidative stress and end-organ dysfunction, not refractory hypotension, in heme oxygenase-1-deficient mice. Circulation, 102, 3015-3022.
34. WILLIS, D., MOORE, A.R., FREDERICK, R. & WILLOUGHBY, D.A. (1996). Heme oxygenase: a novel target for the modulation of inflammatory response. Nat. Med., 2, 87-90.
35. YACHIE, A., NIIDA, Y., WADA, T., IGARASHI, N., KANEDA, H., TOMA, T., OHTA, K., KASAHARA, Y. & KOIZUMI, S. (1999). Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J. Clin. Invest., 103, 129-135.